BVS News and Press, Bioventus Inc. From 04/05/23

2023-04-05 08:16:31 ET Bioventus ( NASDAQ: BVS ) has announced that Ken M. Reali has stepped down as CEO and as a member of the Board of Directors. The board has initiated a comprehensive search process to identify a permanent CEO. Until a successor is named,...

DURHAM, N.C., April 05, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced that Ken M. Reali has stepped down as Chief Executive Officer (CEO) and as a member of the Boa...

2023-03-31 14:56:03 ET Bioventus Inc. (BVS) Q4 2022 Earnings Conference Call March 31, 2023 8:30 AM ET Company Participants Dave Crawford - Vice President, Investor Relations Ken Reali - Chief Executive Officer Mark Singleton - Senior Vice President and Chief Fin...

2023-03-31 09:17:00 ET Bioventus ( NASDAQ: BVS ) entered into an amendment to the credit and guaranty agreement, between the company, Wells Fargo Bank, National Association as Administrative Agent and Collateral Agent, and the lenders from time to time party thereto, dated as ...

2023-03-31 08:58:20 ET Bioventus press release ( NASDAQ: BVS ): Q4 Non-GAAP EPS of -$0.06 misses by $0.11 . Revenue of $125.83M (-3.5% Y/Y) misses by $6.87M . Non-GAAP gross profit was $89.6 million, or 71.2% of net sales, compared to $99.6 million, or 76....

DURHAM, N.C., March 31, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active healing, today reported financial results for the year ended December 31, 2022. Q4 Financial Summary & Recent Highlights: ...

DURHAM, N.C., March 31, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced today that it has entered into an Amendment No. 4 (the “Amendment”) to the Credi...

DURHAM, N.C., March 29, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will now report financial results for the fourth quarter of fiscal year 2022 bef...

DURHAM, N.C., March 16, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report financial results for the fourth quarter of fiscal year 2022 before ...

SAN DIEGO, March 07, 2023 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a deadline is coming up on March 13th in the lawsuit that was filed for certain investors in shares of Bioventus Inc. (NASDAQ: BVS). Investors with losses in excess of $100,000 with shares of Bioven...